Animal Models of Peripheral Neuropathies

被引:57
作者
Hoeke, Ahmet [1 ,2 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Neurol, Johns Hopkins Hosp, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Neurosci, Johns Hopkins Hosp, Baltimore, MD 21205 USA
基金
美国国家卫生研究院;
关键词
Diabetic neuropathy; Diabetic autonomic neuropathy; Chemotherapy; Toxic neuropathy; Human immunodeficiency virus; HIV-associated sensory neuropathy; STREPTOZOTOCIN-DIABETIC RATS; ALDOSE REDUCTASE INHIBITION; CONTROLLED-RELEASE OXYCODONE; RANDOMIZED CONTROLLED-TRIAL; PAINFUL SENSORY NEUROPATHY; TAXOL-INDUCED NEUROPATHY; NERVE-FIBER DENSITY; AUTONOMIC NEUROPATHY; LENTIVIRUS INFECTION; MECHANICAL HYPERALGESIA;
D O I
10.1007/s13311-012-0116-y
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Peripheral neuropathies are common neurological diseases, and various animal models have been developed to study disease pathogenesis and test potential therapeutic drugs. Three commonly studied disease models with huge public health impact are diabetic peripheral neuropathy, chemotherapy-induced peripheral neuropathy, and human immunodeficiency virus-associated sensory neuropathies. A common theme in these animal models is the comprehensive use of pathological, electrophysiological, and behavioral outcome measures that mimic the human disease. In recent years, the focus has shifted to the use of outcome measures that are also available in clinical use and can be done in a blinded and quantitative manner. One such evaluation tool is the evaluation of epidermal innervation with a simple skin biopsy. Future clinical trials will be needed to validate the translational usefulness of this outcome measure and validation against accepted outcome measures that rely on clinical symptoms or examination findings in patients.
引用
收藏
页码:262 / 269
页数:8
相关论文
共 118 条
  • [1] MECHANICAL HYPERALGESIA IN STREPTOZOTOCIN-DIABETIC RATS
    AHLGREN, SC
    LEVINE, JD
    [J]. NEUROSCIENCE, 1993, 52 (04) : 1049 - 1055
  • [2] NERVE GROWTH-FACTOR PREVENTS TOXIC NEUROPATHY IN MICE
    APFEL, SC
    LIPTON, RB
    AREZZO, JC
    KESSLER, JA
    [J]. ANNALS OF NEUROLOGY, 1991, 29 (01) : 87 - 90
  • [3] APFEL SC, 1993, ANN NY ACAD SCI, V692, P243
  • [4] NERVE GROWTH-FACTOR PREVENTS EXPERIMENTAL CISPLATIN NEUROPATHY
    APFEL, SC
    AREZZO, JC
    LIPSON, L
    KESSLER, JA
    [J]. ANNALS OF NEUROLOGY, 1992, 31 (01) : 76 - 80
  • [5] Chemotherapy-induced peripheral neurotoxicity (CIPN): An update
    Argyriou, Andreas A.
    Bruna, Jordi
    Marmiroli, Paola
    Cavaletti, Guido
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 82 (01) : 51 - 77
  • [6] LIGHT AND ELECTRON MICROSCOPY OF LESIONS IN RATS RENDERED DIABETIC WITH STREPTOZOTOCIN
    ARISON, RN
    CIACCIO, EI
    GLITZER, MS
    CASSARO, JA
    PRUSS, MP
    [J]. DIABETES, 1967, 16 (01) : 51 - +
  • [7] NERVE BIOPSY AND CONDUCTION STUDIES IN DIABETIC NEUROPATHY
    BEHSE, F
    BUCHTHAL, F
    CARLSEN, F
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1977, 40 (11) : 1072 - 1082
  • [8] Diabetic somatic neuropathies
    Boulton, AJM
    Malik, RA
    Arezzo, JC
    Sosenko, JM
    [J]. DIABETES CARE, 2004, 27 (06) : 1458 - 1486
  • [9] DISTAL NEUROPATHY IN EXPERIMENTAL DIABETES-MELLITUS
    BROWN, MJ
    SUMNER, AJ
    GREENE, DA
    DIAMOND, SM
    ASBURY, AK
    [J]. ANNALS OF NEUROLOGY, 1980, 8 (02) : 168 - 178
  • [10] Distal degenerative sensory neuropathy in a long-term type 2 diabetes rat model
    Brussee, Valentine
    Guo, GuiFang
    Dong, YingYing
    Cheng, Chu
    Martinez, Jose A.
    Smith, Darrell
    Glazner, Gordon W.
    Fernyhough, Paul
    Zochodne, Douglas W.
    [J]. DIABETES, 2008, 57 (06) : 1664 - 1673